Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals in Adults of Child-Bearing Age

Environmental Exposure Clinical Trial

Official title:

Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals (EDCs) in Women of Child-Bearing Age and Their Partners

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05780047
• Other study ID #: 1R43ES034312-01
• Status: Completed
• Phase: N/A
• Start date: May 1, 2022
• Est. completion date: October 31, 2022

Study information

• Verified date: March 2023
• Source: Million Marker Wellness, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this intervention study is to determine to what extent the Million Marker (MM) program reduces users' endocrine disruption chemical (EDC) exposure levels and changes their environmental health awareness and behaviors. The main questions it aims to answer are: - Can the investigators see a reduction in EDC levels in participants' urine samples after using the MM Detect and Detox kit? - Can the investigators see a change in participants' environmental health literacy, knowledge, and behaviors after using MM's products and services? - How can Million Marker improve their app and platform to improve the user experience? Participants will collect their urine pre- and post-intervention, and will take a comprehensive exposure survey (via the MM app) before sending back their samples. This exposure survey will ask about participant's product use, diet, and lifestyle behaviors. Participants will also fill out surveys pre- and post-intervention assessing their perception of environmental health, as well as usability of the platform.

Description:

Exposures to endocrine disrupting chemicals (EDCs) have been linked to chronic diseases and conditions including breast cancer, metabolic syndrome, diabetes, and infertility. Timing of exposure, especially during pregnancy, may have a lifelong impact on the fetus, including neurodevelopmental problems and asthma. However, there have been no tools to allow those in the preconception, conception, and pregnancy stages to assess EDC exposures to ensure a healthy pregnancy and normal child development. Million Marker (MM) was born to fill this need. MM is a precision health company, built by a team of multidisciplinary scientists who are trained in environmental epidemiology, toxicology, analytical chemistry, biostatistics, data engineering, and business. MM's missions are to crowdsource and scale the biomonitoring of environmental chemicals and provide actionable results to consumers in a timely manner in order to empower individuals to proactively assess, track, and reduce their harmful environmental exposures. Starting with a few biomarkers of common EDCs, MM's ultimate vision is to discover all possible ("a million") biomarkers of harmful exposures to inform and improve individual health outcomes and advance precision medicine. Less than a year after it was founded, Million Marker developed and sold the first product-a mail-in urine test for BPA and phthalates-and successfully helped users reduce exposures through personalized intervention plans. Customers are able to order a test kit online, receive the test kit via mail, take a comprehensive exposure survey (via the Million Marker app), send back samples via mail, view personalized reports with tailored product recommendations through a secure online portal, make lifestyle changes to reduce exposures, and retest to monitor progress. MM's initial target audience are individuals of reproductive age, due to the vulnerability pregnancy and preconception to EDC exposures. However, it is unclear to what extent the MM platform educates, motivates, and ultimately reduces EDC exposure in individuals in this age range. Therefore, the aims of the current proposal are to 1) test and validate a this first-of-its-kind mobile EDC reduction program in a prospective longitudinal cohort intervention trial; 2) assess changes in participants' environmental health literacy, attitudes, knowledge, and behaviors after using MM's products and services; and 3) evaluate the MM app and platform usability to improve the user experience. Validating this population with MM's program is a step towards these types of future studies. At the conclusion of the project, MM will be well-positioned to begin Phase II and will scale the EDCs testing and personalized intervention plan to fertility clinics and the general public.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 220
• Est. completion date: October 31, 2022
• Est. primary completion date: October 31, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• ages 18-40 years
• in good health, not pregnant, free from diabetes or known kidney disease or cancer (these conditions may interfere with EDC metabolism)
• able to understand written and spoken English
• already consented for re-contact with the Healthy Nevada Project
• owning a smartphone
• willing to complete all study assessments

Exclusion Criteria:

• only one woman and her partner per household will be enrolled

Related Conditions & MeSH terms

• Bisphenol A
• Endocrine Disrupting Chemicals
• Environmental Exposure
• Health Literacy
• Phthalate Exposure
• Survey

Intervention

Diagnostic Test:
• Mail-in Urine Test for EDCs
Million Marker provides a mail-in urine test for Bisphenol A (BPA) and phthalates. Users take a comprehensive exposure survey (via the MM app), send back their samples, view their personalized reports with tailored product recommendations, make changes to reduce their exposures, and retest to monitor their progress. Participants will also fill out surveys to assess changes in their environmental health literacy, readiness to change, and analyses of lifestyle behaviors and product use.

Locations

Country	Name	City	State
United States	Million Marker Wellness Inc.	Berkeley	California

Sponsors (1)

Lead Sponsor	Collaborator
Million Marker Wellness, Inc.

Country where clinical trial is conducted

United States, 

References & Publications (73)

Ackerman JM, Dodson RE, Engel CL, Gray JM, Rudel RA. Temporal variability of urinary di(2-ethylhexyl) phthalate metabolites during a dietary intervention study. J Expo Sci Environ Epidemiol. 2014 Nov;24(6):595-601. doi: 10.1038/jes.2013.93. Epub 2014 Jan 22. — View Citation

American College of Obstetricians and Gynecologists' Committee on Obstetric Practice. Reducing Prenatal Exposure to Toxic Environmental Agents: ACOG Committee Opinion, Number 832. Obstet Gynecol. 2021 Jul 1;138(1):e40-e54. doi: 10.1097/AOG.0000000000004449. — View Citation

American Council on Exercise. Readiness to Change Questionnaire. 2014.

Apple Inc. App Store. 2020. https://www.apple.com/ios/app-store/

Attina TM, Hauser R, Sathyanarayana S, Hunt PA, Bourguignon JP, Myers JP, DiGangi J, Zoeller RT, Trasande L. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis. Lancet Diabetes Endocrinol. 2016 Dec;4(12):996-1003. doi: 10.1016/S2213-8587(16)30275-3. Epub 2016 Oct 17. — View Citation

Birnbaum LS, Jung P. From endocrine disruptors to nanomaterials: advancing our understanding of environmental health to protect public health. Health Aff (Millwood). 2011 May;30(5):814-22. doi: 10.1377/hlthaff.2010.1225. — View Citation

Bocato MZ, Bianchi Ximenez JP, Hoffmann C, Barbosa F. An overview of the current progress, challenges, and prospects of human biomonitoring and exposome studies. J Toxicol Environ Health B Crit Rev. 2019;22(5-6):131-156. doi: 10.1080/10937404.2019.1661588. Epub 2019 Sep 5. — View Citation

Bowes DA, Halden RU. Breast Cancer and Dietary Intake of Endocrine Disruptors: a Review of Recent Literature. Curr. Pathobiol. Rep. 2019; 7:41-46.

Braun JM. Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. Nat Rev Endocrinol. 2017 Mar;13(3):161-173. doi: 10.1038/nrendo.2016.186. Epub 2016 Nov 18. — View Citation

Calafat AM, Wong LY, Ye X, Reidy JA, Needham LL. Concentrations of the sunscreen agent benzophenone-3 in residents of the United States: National Health and Nutrition Examination Survey 2003--2004. Environ Health Perspect. 2008 Jul;116(7):893-7. doi: 10.1289/ehp.11269. — View Citation

Calafat AM, Ye X, Wong LY, Bishop AM, Needham LL. Urinary concentrations of four parabens in the U.S. population: NHANES 2005-2006. Environ Health Perspect. 2010 May;118(5):679-85. doi: 10.1289/ehp.0901560. Epub 2010 Jan 4. — View Citation

Calkins K, Devaskar SU. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care. 2011 Jul;41(6):158-76. doi: 10.1016/j.cppeds.2011.01.001. — View Citation

Carwile JL, Ye X, Zhou X, Calafat AM, Michels KB. Canned soup consumption and urinary bisphenol A: a randomized crossover trial. JAMA. 2011 Nov 23;306(20):2218-20. doi: 10.1001/jama.2011.1721. No abstract available. — View Citation

CDC. Bisphenol A (BPA) Factsheet. National Biomonitoring Program. 2017. https://www.cdc.gov/biomonitoring/BisphenolA_FactSheet.html

CDC. Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2019, Volume 2. 2019. https://www.cdc.gov/exposurereport/pdf/FourthReport_UpdatedTables_Volume2_Jan2019-508.pdf

CDC. National Center for Health Statistics National Health and Nutrition Examination Survey Overview. https://www.cdc.gov/nchs/data/nhanes/nhanes_13_14/NHANES_Overview_Brochure.pdf.

CDC. NHANES: National Health and Nutrition Examination Survey. 2020. https://www.cdc.gov/nchs/nhanes/index.htm

CDC. State Biomonitoring Programs. National Biomonitoring Program. 2019. https://www.cdc.gov/biomonitoring/state_grants.html

CDC. Updated Tables, January 2019. National Report on Human Exposure to Environmental Chemicals. 2019. https://www.cdc.gov/exposurereport/index.html

Chen CY, Chou YY, Lin SJ, Lee CC. Developing an intervention strategy to reduce phthalate exposure in Taiwanese girls. Sci Total Environ. 2015 Jun 1;517:125-31. doi: 10.1016/j.scitotenv.2015.02.021. Epub 2015 Feb 25. — View Citation

Correia-Sa L, Kasper-Sonnenberg M, Palmke C, Schutze A, Norberto S, Calhau C, Domingues VF, Koch HM. Obesity or diet? Levels and determinants of phthalate body burden - A case study on Portuguese children. Int J Hyg Environ Health. 2018 Apr;221(3):519-530. doi: 10.1016/j.ijheh.2018.02.001. Epub 2018 Feb 6. — View Citation

Dennis KK, Marder E, Balshaw DM, Cui Y, Lynes MA, Patti GJ, Rappaport SM, Shaughnessy DT, Vrijheid M, Barr DB. Biomonitoring in the Era of the Exposome. Environ Health Perspect. 2017 Apr;125(4):502-510. doi: 10.1289/EHP474. Epub 2016 Jul 6. — View Citation

Galloway TS, Baglin N, Lee BP, Kocur AL, Shepherd MH, Steele AM; BPA Schools Study Consortium; Harries LW. An engaged research study to assess the effect of a 'real-world' dietary intervention on urinary bisphenol A (BPA) levels in teenagers. BMJ Open. 2018 Feb 3;8(2):e018742. doi: 10.1136/bmjopen-2017-018742. — View Citation

Gascon M, Casas M, Morales E, Valvi D, Ballesteros-Gomez A, Luque N, Rubio S, Monfort N, Ventura R, Martinez D, Sunyer J, Vrijheid M. Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy. J Allergy Clin Immunol. 2015 Feb;135(2):370-8. doi: 10.1016/j.jaci.2014.09.030. Epub 2014 Oct 30. — View Citation

Ghayda RA, Williams PL, Chavarro JE, Ford JB, Souter I, Calafat AM, Hauser R, Minguez-Alarcon L. Urinary bisphenol S concentrations: Potential predictors of and associations with semen quality parameters among men attending a fertility center. Environ Int. 2019 Oct;131:105050. doi: 10.1016/j.envint.2019.105050. Epub 2019 Jul 31. — View Citation

Google. Google Play Store. 2020. https://play.google.com/store?hl=en_US

Google. Google Trends 'Chemical Free' 2004-present. 2020. https://trends.google.com/trends/explore?date=all&geo=US&q=%2Fm%2F09gd7dm

Grzymski, J. J. et al. The Healthy Nevada Project: rapid recruitment for population health study. 2018. http://biorxiv.org/lookup/doi/10.1101/250274. doi:10.1101/250274.

Guo W, Huen K, Park JS, Petreas M, Crispo Smith S, Block G, Holland N. Vitamin C intervention may lower the levels of persistent organic pollutants in blood of healthy women - A pilot study. Food Chem Toxicol. 2016 Jun;92:197-204. doi: 10.1016/j.fct.2016.04.006. Epub 2016 Apr 23. — View Citation

Gutierrez-Torres DS, Barraza-Villarreal A, Hernandez-Cadena L, Escamilla-Nunez C, Romieu I. Prenatal Exposure to Endocrine Disruptors and Cardiometabolic Risk in Preschoolers: A Systematic Review Based on Cohort Studies. Ann Glob Health. 2018 Jul 27;84(2):239-249. doi: 10.29024/aogh.911. — View Citation

Hagobian T, Smouse A, Streeter M, Wurst C, Schaffner A, Phelan S. Randomized Intervention Trial to Decrease Bisphenol A Urine Concentrations in Women: Pilot Study. J Womens Health (Larchmt). 2017 Feb;26(2):128-132. doi: 10.1089/jwh.2016.5746. Epub 2016 Oct 11. — View Citation

Han M, Lee E. Effectiveness of Mobile Health Application Use to Improve Health Behavior Changes: A Systematic Review of Randomized Controlled Trials. Healthc Inform Res. 2018 Jul;24(3):207-226. doi: 10.4258/hir.2018.24.3.207. Epub 2018 Jul 31. — View Citation

Harley KG, Kogut K, Madrigal DS, Cardenas M, Vera IA, Meza-Alfaro G, She J, Gavin Q, Zahedi R, Bradman A, Eskenazi B, Parra KL. Reducing Phthalate, Paraben, and Phenol Exposure from Personal Care Products in Adolescent Girls: Findings from the HERMOSA Intervention Study. Environ Health Perspect. 2016 Oct;124(10):1600-1607. doi: 10.1289/ehp.1510514. Epub 2016 Mar 7. — View Citation

Healthy Nevada Project. About Us. https://healthynv.org/about/.

Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, Nadal A, Palanza P, Panzica G, Sargis R, Vandenberg LN, Vom Saal F. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017 Mar;68:3-33. doi: 10.1016/j.reprotox.2016.10.001. Epub 2016 Oct 17. — View Citation

Hiatt RA, Brody JG. Environmental Determinants of Breast Cancer. Annu Rev Public Health. 2018 Apr 1;39:113-133. doi: 10.1146/annurev-publhealth-040617-014101. Epub 2018 Jan 12. — View Citation

Hwang S, Lim JE, Choi Y, Jee SH. Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis. BMC Endocr Disord. 2018 Nov 6;18(1):81. doi: 10.1186/s12902-018-0310-y. — View Citation

Hyland C, Bradman A, Gerona R, Patton S, Zakharevich I, Gunier RB, Klein K. Organic diet intervention significantly reduces urinary pesticide levels in U.S. children and adults. Environ Res. 2019 Apr;171:568-575. doi: 10.1016/j.envres.2019.01.024. Epub 2019 Feb 12. — View Citation

Ji K, Lim Kho Y, Park Y, Choi K. Influence of a five-day vegetarian diet on urinary levels of antibiotics and phthalate metabolites: a pilot study with "Temple Stay" participants. Environ Res. 2010 May;110(4):375-82. doi: 10.1016/j.envres.2010.02.008. Epub 2010 Mar 12. — View Citation

Kalkbrenner AE, Schmidt RJ, Penlesky AC. Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence. Curr Probl Pediatr Adolesc Health Care. 2014 Nov;44(10):277-318. doi: 10.1016/j.cppeds.2014.06.001. Epub 2014 Sep 5. — View Citation

Kelley AS, Banker M, Goodrich JM, Dolinoy DC, Burant C, Domino SE, Smith YR, Song PXK, Padmanabhan V. Early pregnancy exposure to endocrine disrupting chemical mixtures are associated with inflammatory changes in maternal and neonatal circulation. Sci Rep. 2019 Apr 1;9(1):5422. doi: 10.1038/s41598-019-41134-z. — View Citation

Lehmler HJ, Liu B, Gadogbe M, Bao W. Exposure to Bisphenol A, Bisphenol F, and Bisphenol S in U.S. Adults and Children: The National Health and Nutrition Examination Survey 2013-2014. ACS Omega. 2018 Jun 30;3(6):6523-6532. doi: 10.1021/acsomega.8b00824. Epub 2018 Jun 18. — View Citation

Lichtveld MY, Covert HH, Sherman M, Shankar A, Wickliffe JK, Alcala CS. Advancing Environmental Health Literacy: Validated Scales of General Environmental Health and Environmental Media-Specific Knowledge, Attitudes and Behaviors. Int J Environ Res Public Health. 2019 Oct 28;16(21):4157. doi: 10.3390/ijerph16214157. — View Citation

Machtinger R, Gaskins AJ, Racowsky C, Mansur A, Adir M, Baccarelli AA, Calafat AM, Hauser R. Urinary concentrations of biomarkers of phthalates and phthalate alternatives and IVF outcomes. Environ Int. 2018 Feb;111:23-31. doi: 10.1016/j.envint.2017.11.011. Epub 2017 Nov 20. — View Citation

Meeker JD, Ferguson KK. Urinary phthalate metabolites are associated with decreased serum testosterone in men, women, and children from NHANES 2011-2012. J Clin Endocrinol Metab. 2014 Nov;99(11):4346-52. doi: 10.1210/jc.2014-2555. Epub 2014 Aug 14. — View Citation

Michie S, Yardley L, West R, Patrick K, Greaves F. Developing and Evaluating Digital Interventions to Promote Behavior Change in Health and Health Care: Recommendations Resulting From an International Workshop. J Med Internet Res. 2017 Jun 29;19(6):e232. doi: 10.2196/jmir.7126. — View Citation

Milne-Ives M, Lam C, Van Velthoven MH, Meinert E. Mobile Apps for Health Behavior Change: Protocol for a Systematic Review. JMIR Res Protoc. 2020 Jan 30;9(1):e16931. doi: 10.2196/16931. — View Citation

Mustieles V, Zhang Y, Yland J, Braun JM, Williams PL, Wylie BJ, Attaman JA, Ford JB, Azevedo A, Calafat AM, Hauser R, Messerlian C. Maternal and paternal preconception exposure to phenols and preterm birth. Environ Int. 2020 Apr;137:105523. doi: 10.1016/j.envint.2020.105523. Epub 2020 Feb 29. — View Citation

NCHS. National Health and Nutrition Examination Survey Overview. 2020. https://www.cdc.gov/nchs/data/nhanes/nhanes_13_14/NHANES_Overview_Brochure.pdf

Oikonomidi T, Vivot A, Tran VT, Riveros C, Robin E, Ravaud P. A Methodologic Systematic Review of Mobile Health Behavior Change Randomized Trials. Am J Prev Med. 2019 Dec;57(6):836-843. doi: 10.1016/j.amepre.2019.07.008. — View Citation

Oulhote Y, Lanphear B, Braun JM, Webster GM, Arbuckle TE, Etzel T, Forget-Dubois N, Seguin JR, Bouchard MF, MacFarlane A, Ouellet E, Fraser W, Muckle G. Gestational Exposures to Phthalates and Folic Acid, and Autistic Traits in Canadian Children. Environ Health Perspect. 2020 Feb;128(2):27004. doi: 10.1289/EHP5621. Epub 2020 Feb 19. — View Citation

Paciencia I, Cavaleiro Rufo J, Silva D, Martins C, Mendes F, Farraia M, Delgado L, de Oliveira Fernandes E, Padrao P, Moreira P, Severo M, Barros H, Moreira A. Exposure to indoor endocrine-disrupting chemicals and childhood asthma and obesity. Allergy. 2019 Jul;74(7):1277-1291. doi: 10.1111/all.13740. Epub 2019 Mar 5. — View Citation

Partridge SR, Redfern J. Strategies to Engage Adolescents in Digital Health Interventions for Obesity Prevention and Management. Healthcare (Basel). 2018 Jun 21;6(3):70. doi: 10.3390/healthcare6030070. — View Citation

Paulose T, Speroni L, Sonnenschein C, Soto AM. Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer. Reprod Toxicol. 2015 Jul;54:58-65. doi: 10.1016/j.reprotox.2014.09.012. Epub 2014 Sep 30. — View Citation

Peng CY, Tsai EM, Kao TH, Lai TC, Liang SS, Chiu CC, Wang TN. Canned food intake and urinary bisphenol a concentrations: a randomized crossover intervention study. Environ Sci Pollut Res Int. 2019 Sep;26(27):27999-28009. doi: 10.1007/s11356-019-05534-y. Epub 2019 Jul 27. — View Citation

Pew Research Center. Mobile Fact Sheet. Internet & Technology. 2019. https://www.pewresearch.org/internet/fact-sheet/mobile/

Raghavan R, Romano ME, Karagas MR, Penna FJ. Pharmacologic and Environmental Endocrine Disruptors in the Pathogenesis of Hypospadias: a Review. Curr Environ Health Rep. 2018 Dec;5(4):499-511. doi: 10.1007/s40572-018-0214-z. — View Citation

Rappaport SM, Smith MT. Epidemiology. Environment and disease risks. Science. 2010 Oct 22;330(6003):460-1. doi: 10.1126/science.1192603. — View Citation

Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol. 2013 Dec;42:132-55. doi: 10.1016/j.reprotox.2013.08.008. Epub 2013 Aug 30. — View Citation

Rock Health. Healthcare consumers in a digital transition. Results from our third national consumer survey (2017 data) on digital health adoption and sentiments. 2020. https://rockhealth.com/reports/healthcare-consumers-in-a-digital-transition/

Rudel RA, Gray JM, Engel CL, Rawsthorne TW, Dodson RE, Ackerman JM, Rizzo J, Nudelman JL, Brody JG. Food packaging and bisphenol A and bis(2-ethyhexyl) phthalate exposure: findings from a dietary intervention. Environ Health Perspect. 2011 Jul;119(7):914-20. doi: 10.1289/ehp.1003170. Epub 2011 Mar 30. — View Citation

Sathyanarayana S, Alcedo G, Saelens BE, Zhou C, Dills RL, Yu J, Lanphear B. Unexpected results in a randomized dietary trial to reduce phthalate and bisphenol A exposures. J Expo Sci Environ Epidemiol. 2013 Jul;23(4):378-84. doi: 10.1038/jes.2013.9. Epub 2013 Feb 27. — View Citation

Sawesi S, Rashrash M, Phalakornkule K, Carpenter JS, Jones JF. The Impact of Information Technology on Patient Engagement and Health Behavior Change: A Systematic Review of the Literature. JMIR Med Inform. 2016 Jan 21;4(1):e1. doi: 10.2196/medinform.4514. — View Citation

Street ME, Angelini S, Bernasconi S, Burgio E, Cassio A, Catellani C, Cirillo F, Deodati A, Fabbrizi E, Fanos V, Gargano G, Grossi E, Iughetti L, Lazzeroni P, Mantovani A, Migliore L, Palanza P, Panzica G, Papini AM, Parmigiani S, Predieri B, Sartori C, Tridenti G, Amarri S. Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting. Int J Mol Sci. 2018 Jun 2;19(6):1647. doi: 10.3390/ijms19061647. — View Citation

Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Hunt PM, Rudel R, Sathyanarayana S, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. Andrology. 2016 Jul;4(4):565-72. doi: 10.1111/andr.12178. Epub 2016 Mar 22. — View Citation

U.S. Department of Health and Human Services. System Usability Scale (SUS). 2020. https://www.usability.gov/how-to-and-tools/methods/system-usability-scale.html

van der Vaart R, Drossaert C. Development of the Digital Health Literacy Instrument: Measuring a Broad Spectrum of Health 1.0 and Health 2.0 Skills. J Med Internet Res. 2017 Jan 24;19(1):e27. doi: 10.2196/jmir.6709. — View Citation

Veiga-Lopez A, Kannan K, Liao C, Ye W, Domino SE, Padmanabhan V. Gender-Specific Effects on Gestational Length and Birth Weight by Early Pregnancy BPA Exposure. J Clin Endocrinol Metab. 2015 Nov;100(11):E1394-403. doi: 10.1210/jc.2015-1724. Epub 2015 Sep 25. — View Citation

Walker DI, Valvi D, Rothman N, Lan Q, Miller GW, Jones DP. The metabolome: A key measure for exposome research in epidemiology. Curr Epidemiol Rep. 2019;6:93-103. Epub 2019 Apr 26. — View Citation

WHO. Human Biomonitoring: Facts and Figures. 2015. http://www.euro.who.int/__data/assets/pdf_file/0020/276311/Human-biomonitoring-facts-figures-en.pdf

Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1847-50. doi: 10.1158/1055-9965.EPI-05-0456. No abstract available. — View Citation

Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012 Feb;41(1):24-32. doi: 10.1093/ije/dyr236. Epub 2012 Jan 31. No abstract available. — View Citation

Woods MM, Lanphear BP, Braun JM, McCandless LC. Gestational exposure to endocrine disrupting chemicals in relation to infant birth weight: a Bayesian analysis of the HOME Study. Environ Health. 2017 Oct 27;16(1):115. doi: 10.1186/s12940-017-0332-3. — View Citation

* Note: There are 73 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in endocrine disrupting chemical (EDC) levels	Urine samples collected pre- and post-intervention to measure changes in EDC levels	Outcomes will be assessed at baseline (0-4 weeks) and up to 24 weeks for post-intervention
Secondary	Changes in environmental health literacy using the Environmental Literacy Survey	Validated survey on environmental health literacy will be conducted at baseline and upon completion of the second test. The surveys will be compared for changes.	Outcomes will be assessed at baseline (0-4 weeks) and up to 24 weeks for post-intervention
Secondary	Changes in readiness to change using the Readiness to Change Survey	Validated survey on readiness to change will be conducted at baseline and upon completion of the second test. The surveys will be compared for changes.	Outcomes will be assessed at baseline (0-4 weeks) and up to 24 weeks for post-intervention
Secondary	Changes in digital health literacy using the Digital Health Literacy Instrument	Validated survey on digital health literacy will be conducted at baseline and upon completion of the second test. The surveys will be compared for changes.	Outcomes will be assessed at baseline (0-4 weeks) and up to 24 weeks for post-intervention